531 related articles for article (PubMed ID: 6229873)
1. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
2. Unaltered immunocompetence in patients with non-disseminated breast cancer at the time of diagnosis.
Ludwig CU; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Cancer; 1985 Apr; 55(8):1673-8. PubMed ID: 3872158
[TBL] [Abstract][Full Text] [Related]
3. Study of B and T lymphocyte surface markers in breast cancer patients using anti-B and anti-T cell monoclonal antibodies.
Nowak JS; Lanzrein C
Neoplasma; 1984; 31(3):281-9. PubMed ID: 6610835
[TBL] [Abstract][Full Text] [Related]
4. Normal values of peripheral lymphocyte populations and T cell subsets at a fixed time of day: a flow cytometric analysis with monoclonal antibodies in 210 healthy adults.
Ohta Y; Fujiwara K; Nishi T; Oka H
Clin Exp Immunol; 1986 Apr; 64(1):146-9. PubMed ID: 2942319
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody-defined phenotypes of regional lymph node and peripheral blood lymphocyte subpopulations in early breast cancer.
Morton BA; Ramey WG; Paderon H; Miller RE
Cancer Res; 1986 Apr; 46(4 Pt 2):2121-6. PubMed ID: 3081262
[TBL] [Abstract][Full Text] [Related]
6. Functional and surface phenotype study of lymphocyte subsets in peripheral blood and lymph nodes of breast cancer patients.
Mantovani G; Serri FG; Macciò A; Castelli P; Benedetti P; Scambia G; Santus S; Paderi R; Murtas MG; Ferreli A
Cancer Detect Prev; 1989; 13(5-6):323-32. PubMed ID: 2743354
[TBL] [Abstract][Full Text] [Related]
7. [Subset analysis of tumor infiltrating lymphocytes and peripheral blood lymphocytes in malignant glioma patients].
Matsuhisa T
No To Shinkei; 1995 May; 47(5):466-73. PubMed ID: 7786623
[TBL] [Abstract][Full Text] [Related]
8. Helper and suppressor T lymphocyte function in severe alcoholic liver disease.
McKeever U; O'Mahony C; Whelan CA; Weir DG; Feighery C
Clin Exp Immunol; 1985 Apr; 60(1):39-48. PubMed ID: 3159525
[TBL] [Abstract][Full Text] [Related]
9. [Cellular immunity in breast cancer patients].
Spielmann M; Kitschke HJ; Tietje K
Onkologie; 1982 Aug; 5 Suppl():42-5. PubMed ID: 6752790
[TBL] [Abstract][Full Text] [Related]
10. Deficient concanavalin-A-induced suppressor cell activity in women with untreated breast cancer.
Gupta S; Cunningham-Rundles S
J Clin Lab Immunol; 1982 Dec; 9(3):159-61. PubMed ID: 6220154
[TBL] [Abstract][Full Text] [Related]
11. Characterization of immunoregulatory T lymphocytes during ageing by monoclonal antibodies.
Mascart-Lemone F; Delespesse G; Servais G; Kunstler M
Clin Exp Immunol; 1982 Apr; 48(1):148-54. PubMed ID: 6211314
[TBL] [Abstract][Full Text] [Related]
12. Membrane phenotype and functional behaviour of T lymphocytes in multiple myeloma: correlation with clinical stages of the disease.
Lauria F; Foa R; Cavo M; Gobbi M; Raspadori D; Giubellino MC; Tazzari PL; Tura S
Clin Exp Immunol; 1984 Jun; 56(3):653-8. PubMed ID: 6235070
[TBL] [Abstract][Full Text] [Related]
13. Lymphocyte profiles in patients with chronic low back pain enrolled in a clinical trial.
Brennan PC; Graham MA; Triano JJ; Hondras MA; Anderson RJ
J Manipulative Physiol Ther; 1994 May; 17(4):219-27. PubMed ID: 8046277
[TBL] [Abstract][Full Text] [Related]
14. [Immunophenotyping of lymphocyte subpopulations using monoclonal antibodies in an analytical flow cytometer: evaluation of the method and reference values].
Neumeier D; Pauls R; Wifling I; Fateh-Moghadam A; Knedel M
J Clin Chem Clin Biochem; 1985 Nov; 23(11):765-75. PubMed ID: 4086981
[TBL] [Abstract][Full Text] [Related]
15. Immune status in Crohn's disease. VI. Immunoregulation evaluated by multiple, distinct T-suppressor cell assays of lymphocyte proliferation, and by enumeration of immunoregulatory T-lymphocyte subsets.
Auer IO; Röder A; Fröhlich J
Gastroenterology; 1984 Jun; 86(6):1531-43. PubMed ID: 6232166
[TBL] [Abstract][Full Text] [Related]
16. [Two-color analysis of lymphocyte subpopulations in membranous nephropathy and minimal change nephrotic syndrome].
Ozaki T
Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):797-806. PubMed ID: 2593316
[TBL] [Abstract][Full Text] [Related]
17. Critical evaluation of lymphocyte functions in urological cancer patients.
Elhilali MM; Paika KD; Brosman S; Fahey JL
Cancer Res; 1976 Jan; 36(1):132-7. PubMed ID: 1082369
[TBL] [Abstract][Full Text] [Related]
18. [The effect of sera of breast cancer patients on NK cell activity].
Konjević G; Spuzić I
Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
20. A serial study of peripheral blood T lymphocyte subsets in relapsing-remitting multiple sclerosis.
Kastrukoff LF; Paty DW
Ann Neurol; 1984 Mar; 15(3):250-6. PubMed ID: 6232891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]